Preliminary application and efficacy analysis of robotic transumbilical single-incision plus one port total mesorectal excision for colorectal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026988

Enrollment

Unknown

Registered

2019-10-28

Start date

2019-10-28

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

experimental group:applicate transumbilical single-incision plus one port

control group:CME/TME

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18 years < age < 80 years; 2. Tumor located in colon and high rectum (the lower border of the tumor is above the peritoneal reflection); 3. Pathological colorectal carcinoma; 4. Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 8th Edition of AJCC Cancer Staging Manual; 5. Tumor size of 5 cm or less; 6. ECOG score is 0-1; 7. ASA score is I-III; 8. Informed consent.

Exclusion criteria

Exclusion criteria: 1. Body mass index (BMI) >30 kg/m2; 2. Pregnant woman or lactating woman; 3. Severe mental disease; 4. Previous abdominal surgery (except appendectomy and cholecystotomy); 5. Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer.

Design outcomes

Primary

Measure	Time frame
clinical efficacy;	—

Secondary

Measure	Time frame
Operative time;Intraoperative blood loss;Incision length;Lymph nodes harvested;	—

Countries

China

Contacts

Public ContactFan Li

Army Medical Center of PLA (Daping Hospital)

levinecq@163.com+86 18696539200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026